EFTA00949286.pdf

From: Adam Bly To: Jeffrey Epstein <[email protected]> Subject: Re: Promissory Note Date: Thu, 29 Nov 2012 00:18:48 +0000 just because we asked.... it would help us with year-end cash planning if you're not amenable, I understand and I'll ask Vera to just propose a payment schedule for the full amount. On Nov 28, 2012, at 12:29 PM, Jeffrey Epstein wrote: why should we discount amount owed?? i don't understand On Wed, Nov 28, 2012 at 10:48 AM, Adam Bly > wrote: Begin forwarded message: From: Vera Savcic < Date: November 28, 2012 10:42:32 AM EST To: Adam Bly Subject: Promissory Note Revised Payment Proposal Based on $300k Principal at 24% Default Rate, 365 day basis Full year interest = $72k with payments to be made as follows: - Monthly payments of $3k each for 12 months beginning December 2012 = $36k - Balance of $36k to be paid in 4 installments of $9k each on Aug 31, Sept 30, Oct 31 and Nov 30, 2013 — or earlier - 5 business-day cure period applies We also propose settling the interest payment due for September October and November 2012 in the amount of $10k. Vera Savcic COO & CFO Seed Tel +1 EFTA00949286 The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved Adam Bly Founder & CEO Seed T +1 646 502-7041 I F +1 646 502-7040 I @Seed @adambly NOTICE: If received in error, please destroy and notify sender, and make no further use, disclosure, or distribution. This email and any attachments may contain information subject to confidentiality obligations, and sender does not waive confidentiality or privilege. EFTA00949287